Literature DB >> 7724238

A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man.

A J Fulford1, A E Butterworth, J H Ouma, R F Sturrock.   

Abstract

Dynamic models which predict changes in the intensity of schistosome infection with host age are fitted to pre-intervention Schistosoma mansoni data from Kenya. Age-specific post-treatment-reinfection data are used to estimate the force of infection, thus enabling investigation of the rate of worm death. An empirical and statistical approach is taken to the model fitting: where possible, distributional properties and function relationships are obtained from the data rather than assumed from theory. Attempts are made to remove known sources of bias. Maximum likelihood techniques, employed to allow for error in both the pre-intervention and reinfection data, yield confidence intervals for the worm life-span (CI95% = 5.7-10.5 years) and demonstrate that the worm death rate is unlikely to vary with host age. The possibilities and limitations of fitting dynamic models to data are discussed. We conclude that a detailed, quantitative approach will be necessary if progress is to be made with the interpretation of epidemiological data and the models intended to describe them.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724238     DOI: 10.1017/s0031182000080896

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  54 in total

1.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Factors associated with resistance to Schistosoma mansoni infection in an endemic area of Bahia, Brazil.

Authors:  Ricardo R Oliveira; Joanemile P Figueiredo; Luciana S Cardoso; Rafael L Jabar; Robson P Souza; Martin T Wells; Edgar M Carvalho; Daniel W Fitzgerald; Kathleen C Barnes; Maria Ilma Araújo; Marshall J Glesby
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 3.  Applying evolutionary genetics to schistosome epidemiology.

Authors:  Michelle L Steinauer; Michael S Blouin; Charles D Criscione
Journal:  Infect Genet Evol       Date:  2010-02-20       Impact factor: 3.342

4.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

5.  Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.

Authors:  Takafira Mduluza; Francisca Mutapi; Tinashe Ruwona; Daniel Kaluka; Nicholas Midzi; Patricia D Ndhlovu
Journal:  Malawi Med J       Date:  2009-12       Impact factor: 0.875

6.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

7.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

8.  Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?

Authors:  Colin M Fitzsimmons; Frances M Jones; Angela Pinot de Moira; Anna V Protasio; Jamal Khalife; Harriet A Dickinson; Edridah M Tukahebwa; David W Dunne
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

9.  Genetic structure of Schstosoma mansoni in western Kenya: the effects of geography and host sharing.

Authors:  M L Steinauer; B Hanelt; L E Agola; G M Mkoji; E S Loker
Journal:  Int J Parasitol       Date:  2009-05-21       Impact factor: 3.981

10.  Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Authors:  Colin M Fitzsimmons; Sarah Joseph; Frances M Jones; Claus M Reimert; Karl F Hoffmann; Francis Kazibwe; Gachuhi Kimani; Joseph K Mwatha; John H Ouma; Edridah M Tukahebwa; Henry C Kariuki; Birgitte J Vennervald; Narcis B Kabatereine; David W Dunne
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.